Recent studies have shown that enhancing AKT1 inhibits JNK3/caspase-3 activation and plays a neuroprotective role in ischaemia/reperfusion-induced cognitive impairment [40, 41]. This evidence concerns the gene CASP3 and Cognitive impairment.